Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1638983-52-4

Post Buying Request

1638983-52-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1638983-52-4 Usage

General Description

(6-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)methanamine, also known as MPMP, is a chemical compound with a molecular formula of C10H12N2. It is a heterocyclic amine that contains a pyrrolopyridine ring system, with a methyl group located at the 6 position of the pyrrole ring. MPMP is often used as a building block in the synthesis of various pharmaceuticals and organic compounds due to its unique structural features. It has been studied for its potential therapeutic applications in the treatment of neurological disorders and cancer. Additionally, MPMP has been shown to exhibit inhibitory effects on certain enzymes, making it a potential candidate for drug development and medicinal chemistry research.

Check Digit Verification of cas no

The CAS Registry Mumber 1638983-52-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,3,8,9,8 and 3 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1638983-52:
(9*1)+(8*6)+(7*3)+(6*8)+(5*9)+(4*8)+(3*3)+(2*5)+(1*2)=224
224 % 10 = 4
So 1638983-52-4 is a valid CAS Registry Number.

1638983-52-4Downstream Products

1638983-52-4Relevant articles and documents

PYRAZOLOPYRIDINE PYRAZOLOPYRIMIDINE AND RELATED COMPOUNDS

-

, (2015/11/25)

In one aspect this invention relates generally to compounds of Formula: and sub-formulas thereof, or a tautomer of each thereof, a pharmaceutically acceptable salt of each thereof, or a pharmaceutically acceptable solvate of each of the foregoing, where X1, L1, L3, and R3 are described herein.

HETEROCYCLIC DERIVATES

-

Page/Page column 85, (2014/12/12)

The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R5, R6, R7, A, B,W, X, Y and Z are as defined herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1638983-52-4